Skip to content

Kumar Budur, Chief Medical Officer at Harmony Biosciences, sold HRMY on Sep 17, 2026

Data as of Oct 16

▼ SELL$34.4K800 shares at $43.00Kumar Budur Chief Medical OfficerHRMY Harmony Biosciences Holdings, Inc.
Watch HRMY
Traded
Sep 17, 2026
Disclosed
Sep 18, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Kumar Budur, Chief Medical Officer at Harmony Biosciences, sold HRMY on Sep 17, 2026TRADEDDISCLOSED
HRMYSimilar stocks (XLV — its sector index fund), rebased to HRMY's price on the disclosure day
HRMY since disclosure
−9.7%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund

Change in closing price from Sep 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKumar Budur Chief Medical OfficerHRMY Harmony Biosciences Holdings, Inc.$1.5Mdisclosed Sep 18 · filed the same day
  2. ▼ SELLKumar Budur Chief Medical OfficerHRMY Harmony Biosciences Holdings, Inc.$77.4Kdisclosed Sep 18 · filed 2 days after the trade

See every trade on HRMY →